Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2023.12.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von Chaowapong Jarasvaraparn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Riley Hospital for Children, Indiana University, 705 Riley Hospital Drive, ROC 4210…. Hauptthemen laut MEDLINE: Hypertension, Portal, Liver Cirrhosis, Biomarkers, Fontan Procedure. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Fontan-associated liver disease (FALD) refers to structural and functional changes of the liver caused by the physiology of the Fontan palliation. Currently, liver biopsy is the gold standard to assess liver fibrosis of FALD. AIM: Investigate biomarkers correlating with severity of liver biopsy fibrosis in FALD. METHODS: A retrospective study of post-Fontan patients ≥ 10 years of age who underwent liver biopsy was conducted. Advanced liver disease (ALD) was defined as bridging fibrosis and/or cirrhosis on liver biopsy. AST-to-platelet ratio index (APRI), Fibrosis-4 (FIB-4) and Liver Stiffness Measurement (LSM) from FibroScan were used as non-invasive fibrosis scores. RESULTS: Sixty-six patients (26/47; 55.3% adults and 13/19 children; 68.4%) had ALD on biopsy. ALD was associated with lower platelet count (151 vs. 198 K/uL, p = 0.003), higher APRI (0.64 vs. 0.32, p = 0.01), higher FIB-4 (0.64 vs. 0.32, p = 0.02). Liver fibrosis score correlated with APRI (0.34, p = 0.02) and FIB-4 (0.47, p = 0.001) in adults. LSM had a high sensitivity at 81.3% with 45.5% specificity at a cut-off 18.5 kPa. CONCLUSIONS: APRI and FIB-4 had modest discrimination to identify adults with advanced liver disease, but not children, indicating that these values may be followed as a marker of FALD progression in older patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Riley Hospital for Children, Indiana University, 705 Riley Hospital Drive, ROC 4210, Indianapolis, Indiana 46202, United States. Electronic address: cjar…
- Division of Pediatric Cardiology, United States.
- Division of Gastroenterology, Hepatology and Nutrition Riley Hospital for Children at IU Health, Indiana University School of Medicine, United States.
- Division of Pediatric Gastroenterology, Hepatology and Nutrition, Riley Hospital for Children, Indiana University, 705 Riley Hospital Drive, ROC 4210, Indianapolis, Indiana 46202, United States.
Zitieren
APA
Jarasvaraparn, C., Thoe, J., Rodenbarger, A., Masuoka, H., Payne, R. M., Markham, L. W., & Molleston, J. P. (2024). Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.12.017
Vancouver
Jarasvaraparn C, Thoe J, Rodenbarger A, Masuoka H, Payne RM, Markham LW, et al. Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2023.12.017
BibTeX
@article{Jarasvaraparn2024,
author = {Jarasvaraparn, Chaowapong and Thoe, Jessica and Rodenbarger, Andrew and Masuoka, Howard and Payne, R Mark and Markham, Larry Wayne and Molleston, Jean P},
title = {Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2023.12.017}
}
EUVIMED